๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Germ Cell Tumor

Medulloblastoma Online Video-based Exercise Pilot Study NCT06898684NA2 sites๐Ÿ“ Mรผnchen๐Ÿ“ Gothenburg Aron Onerup ยท Tests: Exercise Key Longitudinal Associations With Risk and Glioblastoma Outcomes NCT06625684n/a1 site๐Ÿ“ Durham Duke University Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma NCT02605421Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Thiotepa, Cyclophosphamide, Melphalan, Etoposide, Carboplatin A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion NCT04655404EARLY Phase 121 sites๐Ÿ“ Aurora๐Ÿ“ Washington D.C.๐Ÿ“ Chicago Nationwide Children's Hospital ยท Tests: Larotrectinib, Larotrectinib surgical A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment NCT05708352Phase 25 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ Santa Monica Cedars-Sinai Medical Center ยท Tests: Keto Diet, Standard Anti-Cancer Diet A Prospective, Single-arm Clinical Study on the Safety and Efficacy of Ivoximab Combined With Temozolomide in the Treatment of Relapsed/Refractory Glioma NCT07599371Phase 1, Phase 21 site๐Ÿ“ Zhengzhou The First Affiliated Hospital of Zhengzhou University ยท Tests: Ivoximab 20 mg/kg, ivgtt, Q4W, Temozolomide (TMZ) An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Zhengzhou๐Ÿ“ Hangzhou Beijing Tide Pharmaceutical Co., Ltd ยท Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors NCT07536087NA1 site๐Ÿ“ Prague Institute for Clinical and Experimental Medicine ยท Tests: Endoscopic ultrasound-guided radiofrequency ablation for pancreatic cystic lesions, Endoscopic ultrasound-guided radiofโ€ฆ Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma NCT06008106Phase 31 site๐Ÿ“ Beijing Shanghai Kechow Pharma, Inc. ยท Tests: tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma NCT07538128EARLY Phase 11 site๐Ÿ“ Shanghai Huashan Hospital ยท Tests: YSCH-01, Atezolizumab (1200 mg every three weeks) Evaluation of Hypoxia in Primary Melanoma NCT06831071n/a1 site๐Ÿ“ Pittsburgh Yana Najjar ยท Tests: Pimonidazole Naltrexone and Propranolol Combined With Immunotherapy NCT05968690Phase 11 site๐Ÿ“ New Brunswick Sarah Weiss ยท Tests: Propranolol, Naltrexone A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors NCT05366478Phase 11 site๐Ÿ“ Tianjin Suzhou BlueHorse Therapeutics Co., Ltd. ยท Tests: Autologous tumor infiltrating lymphocytes (TILs) Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures NCT07493447EARLY Phase 11 site๐Ÿ“ Nashville Eben Rosenthal ยท Tests: Panitumumab-IRDye800 Timing of Immunotherapy in Melanoma NCT07696715NA5 sites๐Ÿ“ Amsterdam๐Ÿ“ Amsterdam๐Ÿ“ Leiden Radboud University Medical Center ยท Tests: Timing of first administration (early morning), Timing of immunotherapy (afternoon) Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate Precision Medicine for L/GCMN and Melanoma 2 NCT06605443n/a3 sites๐Ÿ“ Barcelona๐Ÿ“ Barcelona๐Ÿ“ Barcelona Fundacion Clinic per a la Recerca Biomรฉdica ยท Tests: Breath analyzer, Skin patch, Liquid biopsy NK Cell Therapy for Malignant Solid Brain Tumors NCT07552233NA4 sites๐Ÿ“ Beijing๐Ÿ“ Qinhuangdao๐Ÿ“ Zhengzhou Peking University Third Hospital ยท Tests: Autologous NK cells Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis NCT07203391Phase 12 sites๐Ÿ“ Sydney๐Ÿ“ Melbourne St Vincent's Hospital, Sydney ยท Tests: roginolisib rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG NCT04943848Phase 13 sites๐Ÿ“ Orange๐Ÿ“ Chicago๐Ÿ“ Boston Ann & Robert H Lurie Children's Hospital of Chicago ยท Tests: rHSC-DIPGVax, Balstilimab, Zalifrelimab A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites๐Ÿ“ Beverly Hills๐Ÿ“ San Francisco๐Ÿ“ Westwood, Los Angeles Fore Biotherapeutics ยท Tests: Plixorafenib Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations NCT07025018Phase 11 site๐Ÿ“ Shanghai Hutchmed ยท Tests: HMPL-306 18F-DOPA II - PET Imaging Optimization NCT04706910Phase 31 site๐Ÿ“ Edmonton University of Alberta ยท Tests: 18F-DOPA, Furosemide Injection Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma NCT06419946Phase 320 sites๐Ÿ“ Graz๐Ÿ“ Innsbruck๐Ÿ“ Linz Vastra Gotaland Region ยท Tests: Temozolomide, Lomustine LITT for Ultra-early GBM Recurrence NCT07616986NA1 site๐Ÿ“ Bern Insel Gruppe AG, University Hospital Bern ยท Tests: LITT AI-driven Processing and Analysis of Glioma Imaging Data NCT07703761n/a1 site๐Ÿ“ Trento Universitร  degli Studi di Trento ยท Tests: AI-driven analysis of brain MRI data for early, non-invasive detection, segmentation, and histological characterizationโ€ฆ Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma NCT07067905EARLY Phase 11 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: 68Ga-XT771 D2C7-IT + 2141-V11 Combination Post-resection in rGBM NCT06455605Phase 11 site๐Ÿ“ Durham Darell Bigner ยท Tests: D2C7-IT, 2141 V11 Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors NCT00870129NA1 site๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: MRI and advanced MRI sequences
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy